Spiro George Rombotis, President & CEO, Director at Cyclacel Pharmaceuticals, holds 68.66K shares in Cyclacel Pharmaceuticals (Ticker: CYCC). Most recently, Spiro George Rombotis Bought $6,070 shares of Cyclacel Pharmaceuticals on Dec 26, 2023 for an estimated value of 20.09K.
What is the percentage of profitable transactions made by Spiro George Rombotis?
The percentage of profitable transactions made by Spiro George Rombotis is 0%.
What is the average return per transaction made by Spiro George Rombotis?
The average return per transaction made by Spiro George Rombotis is -67.80%.
What stocks does Spiro George Rombotis hold?
Spiro George Rombotis holds: CYCC stocks.
What was Spiro George Rombotis’s latest transaction?
Spiro George Rombotis latest transaction was an Informative Buy of $20.09K.
What was Spiro George Rombotis's most profitable transaction?
Spiro George Rombotis’s most profitable transaction was an Informative Buy of CYCC stock on December 26, 2023. The return on the trade was -56.60%.
What is Spiro George Rombotis's role in Cyclacel Pharmaceuticals?
Spiro George Rombotis's role in Cyclacel Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.